Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TAK and other ETFs, options, and stocks.

About TAK

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following business divisions: Gastrointestinal Diseases, Rare Diseases, Plasma-Derived Therapies, Oncology, Vaccines, and Neuroscience The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan. 

CEO
Christophe P. Weber
CEOChristophe P. Weber
Employees
47,029
Employees47,029
Headquarters
Osaka, Osaka
HeadquartersOsaka, Osaka
Founded
1781
Founded1781
Employees
47,029
Employees47,029

TAK Key Statistics

Market cap
49.65B
Market cap49.65B
Price-Earnings ratio
-55.60
Price-Earnings ratio-55.60
Dividend yield
3.82%
Dividend yield3.82%
Average volume
2.95M
Average volume2.95M
High today
$15.60
High today$15.60
Low today
$15.39
Low today$15.39
Open price
$15.39
Open price$15.39
Volume
421.53K
Volume421.53K
52 Week high
$18.90
52 Week high$18.90
52 Week low
$12.99
52 Week low$12.99

TAK News

TipRanks 4d
Takeda’s New Polish Study Tracks Real-World Impact of Fruquintinib in Advanced Colorectal Cancer

Takeda Pharmaceutical Company (TAK) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks...

TipRanks 4d
Takeda’s High-Stakes Overhaul: CEO Transition and Major Restructuring Raise Execution and Profitability Risks

Takeda Pharmaceutical Company (TAK) has disclosed a new risk, in the Corporate Activity and Growth category. Unlock powerful investing tools and data-driven in...

TipRanks 7d
Takeda presents additional results from oveporexton studies at SLEEP 2026

Takeda (TAK) presented additional results from two pivotal studies at SLEEP 2026, showing oveporexton, an oral orexin receptor 2-selective agonist, improved dai...

Analyst ratings

67%

of 15 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.